ANAVEX LIFE SCIENCES CORP.(AVXL)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

ANAVEX LIFE SCIENCES CORP. (AVXL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AVXL at 24.6/100 on a 32-signal composite quality model, placing it at rank #2,858 of 3,068 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (1.2) and institutional flow (7.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 30.0/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of AVXL by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, TWO SIGMA INVESTMENTS, based on the most recent SEC filings. AVXL trades on the Nasdaq exchange and files with the SEC under CIK 1314052. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVXL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ANAVEX LIFE SCIENCES CORP. directly from SEC EDGAR.